Vernakalant
By Business Review Editor
Pharma Deals Review: Vol 2008 Issue 91 (Table of Contents)
Published: 8 Jan-2008
DOI: 10.3833/pdr.v2008.i91.241 ISSN: 1756-7874
Section: Deal Trackers
Fulltext:
Abstract
Vernakalant (RSD1235, 3-pyrrolidinol) is a NCE being developed to treat acute episodes of atrial fi brillation (AF)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS